Cargando…
Is there a distinct phenotype of diabetic patients who benefit from tofogliflozin?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Termedia Publishing House
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374575/ https://www.ncbi.nlm.nih.gov/pubmed/30775590 http://dx.doi.org/10.5114/amsad.2018.74776 |
| _version_ | 1783395186825494528 |
|---|---|
| author | Patoulias, Dimitrios Ioannis |
| author_facet | Patoulias, Dimitrios Ioannis |
| author_sort | Patoulias, Dimitrios Ioannis |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6374575 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Termedia Publishing House |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-63745752019-02-15 Is there a distinct phenotype of diabetic patients who benefit from tofogliflozin? Patoulias, Dimitrios Ioannis Arch Med Sci Atheroscler Dis Letter to the Editor Termedia Publishing House 2018-03-27 /pmc/articles/PMC6374575/ /pubmed/30775590 http://dx.doi.org/10.5114/amsad.2018.74776 Text en Copyright: © 2018 Termedia & Banach http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
| spellingShingle | Letter to the Editor Patoulias, Dimitrios Ioannis Is there a distinct phenotype of diabetic patients who benefit from tofogliflozin? |
| title | Is there a distinct phenotype of diabetic patients who benefit from tofogliflozin? |
| title_full | Is there a distinct phenotype of diabetic patients who benefit from tofogliflozin? |
| title_fullStr | Is there a distinct phenotype of diabetic patients who benefit from tofogliflozin? |
| title_full_unstemmed | Is there a distinct phenotype of diabetic patients who benefit from tofogliflozin? |
| title_short | Is there a distinct phenotype of diabetic patients who benefit from tofogliflozin? |
| title_sort | is there a distinct phenotype of diabetic patients who benefit from tofogliflozin? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374575/ https://www.ncbi.nlm.nih.gov/pubmed/30775590 http://dx.doi.org/10.5114/amsad.2018.74776 |
| work_keys_str_mv | AT patouliasdimitriosioannis isthereadistinctphenotypeofdiabeticpatientswhobenefitfromtofogliflozin |